PVI
APTO

Pura Vida Investments’s Aptose Biosciences, Inc. APTO Stock Holding History

Pura Vida Investments’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-333
Closed -$392K – 134
2019
Q2 		$392K Buy
+333
New +$306K 0.06% 94

Other funds holding APTO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pura Vida Investments's APTO Position: Q3 2019 in Review

Pura Vida Investments sold out of Aptose Biosciences, Inc. (APTO) in Q3 2019, closing a stake of 333 shares — an estimated $392K sold.

Pura Vida Investments first reported a position in APTO in Q2 2019 and held it in 1 quarter. The position peaked at $392K in Q2 2019. 31 funds tracked by Wall St. Rank hold APTO as of Q3 2019.

  • Pura Vida Investments reported no remaining Aptose Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Pura Vida Investments sold 333 Aptose Biosciences, Inc. shares in Q3 2019, an estimated $392K.
  • Pura Vida Investments first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 1 quarter.
  • Pura Vida Investments's Aptose Biosciences, Inc. position peaked at $392K in Q2 2019.
  • 31 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2019.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.